戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 atients possessing one localized periodontal osseous defect.
2 tromal-cell-mediated bone regeneration in an osseous defect.
3 ated to the presence of residual char in the osseous defect.
4 ated to the presence of residual char in the osseous defect.
5 ade of the alveolar crest height and base of osseous defect.
6 anges in bone within the healed peri-implant osseous defect.
7 anges in bone within the healed peri-implant osseous defect.
8  particles and a bone fracture callus on the osseous defect.
9 rane in guided tissue regeneration (GTR) for osseous defects.
10 n patients with localized severe periodontal osseous defects.
11 trabeculae and more trabecular separation in osseous defects.
12 of periodontal surgery and reconstitution of osseous defects.
13 gical therapy of peri-implantitis-associated osseous defects.
14 nd effective in the treatment of periodontal osseous defects.
15 dontal membrane in the treatment of vertical osseous defects.
16 ABM/P-15 in long-term healing of periodontal osseous defects.
17 n suggested for the treatment of periodontal osseous defects.
18  bone replacement graft in human periodontal osseous defects.
19 ts (90.9%) achieved complete coverage of the osseous defects.
20 s placed in sites with extended peri-implant osseous defects.
21 e its potential for treatment of periodontal osseous defects.
22 dement in the treatment of human periodontal osseous defects.
23 DFDBA) in the treatment of human periodontal osseous defects.
24 to the creation of bilateral mandibular 5 mm osseous defects.
25 he vertical and horizontal dimensions of the osseous defects.
26 ene (ePTFE) membrane were utilized to repair osseous defects.
27 ried bone graft (FDBG) to fill rat calvarial osseous defects.
28  derived from different types of periodontal osseous defects.
29 ne matrix (DBM) is used for the treatment of osseous defects.
30 were 1.5 mm greater, and the average fill of osseous defect 2.4 mm greater with EMD than controls.
31                               Full thickness osseous defects (5 mm) were prepared in the cranium of i
32  was to determine which treatment of a large osseous defect adjacent to an endosseous dental implant
33 group C, submerged implants were placed into osseous defects and covered with an ePTFE membrane.
34 up A, nonsubmerged implants were placed into osseous defects and treated with a poncho style ePTFE me
35 med to determine changes in PD, CAL, fill of osseous defect, and crestal resorption.
36 mine changes in GI, PI, PD, CAL, fill of the osseous defect, and crestal resorption.
37 etermining three-dimensional architecture of osseous defects are inadequate.
38 thetic bioabsorbable carrier for BMP used in osseous defects around dental implants in the canine man
39 e are no studies evaluating Scl-Ab to repair osseous defects around teeth or to identify the efficacy
40 ix for the treatment of advanced periodontal osseous defects at 6 months of healing.
41 hickness mucoperiosteal flaps were elevated, osseous defects debrided, and the roots prepared (ultras
42 nd 1.18 mm on lingual sites at center B) and osseous defect fill (1.84 mm on buccal and 2.00 mm on li
43 .08 mm of new vertical bone height and 42.3% osseous defect fill in the HD-PDGF/IGF-I subjects versus
44                   The ABR model was based on osseous defects filled with BB.
45                              Large segmental osseous defects heal poorly.
46  CONCLUSIONS: Diabetes significantly delayed osseous defect healing by augmenting inflammation, impai
47 tite scaffolds did not significantly enhance osseous defect healing compared with controls.
48                         Twenty-four vertical osseous defects in 24 patients were treated with either
49 s compared to ABM alone in human periodontal osseous defects in a controlled, monitored, multi-center
50 flap debridement (DEBR) in human periodontal osseous defects in a controlled, monitored, multi-center
51                                       Paired osseous defects in each subject were randomly selected t
52 factor-I (IGF-I) when applied to periodontal osseous defects in humans; a secondary objective was to
53 are limited data on the healing potential of osseous defects in the human mandible.
54 , low dose delivery did not heal periodontal osseous defects in this study.
55                                              Osseous defect measurements were taken at baseline and a
56 ve applications such as fracture healing and osseous defects of the oral cavity.
57 iameter and 0.5 mm thick through-and-through osseous defects on the mandibular ramus of rats, with un
58 ; and 4) occlusal surface to the base of the osseous defect (OS-BD).
59                                          Two osseous defects per patient were treated randomly with e
60                                        Three osseous defects per patient were treated randomly with o
61 aling, AMC spheroids/FDBG promoted calvarial osseous defect regeneration, and the outcomes were furth
62 ting extraction socket healing and calvarial osseous defect regeneration.
63 is, osteoporosis, cauda equina syndrome, and osseous defect), resulting in a final sample of 412,021
64 arriers proved suitable for achieving GBR of osseous defects surrounding dental implants.
65 regeneration (GBR) is a viable treatment for osseous defects surrounding dental implants.
66 eriodontal or peri-implant diseases to large osseous defects that extend through the jaws as a result
67                             In the calvarial osseous defects, the mineralized tissue ratio was promot
68 end on numerous factors and range from gross osseous defects to equivocal labral abnormalities and un
69 -entry data demonstrate that percent fill of osseous defects treated with EMD compares favorably with
70  genes (DEG) were detected between different osseous defect types.
71 olars were extracted, and a tooth-associated osseous defect was created in the extraction area.
72 cally conditioned with tetracycline, and the osseous defect was grafted with decalcified freeze-dried
73            Radiographic linear resolution of osseous defects was significantly greater after teripara
74                                              Osseous defects were created by extraction of the maxill
75                                   Artificial osseous defects were created on mandibles of dry skulls.
76                                          The osseous defects were then filled with demineralized free
77 ed at the apical extent of the calculus, the osseous defects were thoroughly debrided, and the tooth
78                        Treatment of vertical osseous defects with nonporous or porous polytetrafluoro
79 ants placed directly into surgically created osseous defects with or without expanded polytetrafluoro
80                               Patients had 3 osseous defects with probing depths (PD) > 5 mm after in
81 up B, nonsubmerged implants were placed into osseous defects without an ePTFE membrane.